Osimertinib with Chemotherapy in EGFR-Mutated NSCLC

N Engl J Med. 2024 Feb 1;390(5):478. doi: 10.1056/NEJMc2314600.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acrylamides / therapeutic use
  • Aniline Compounds / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • ErbB Receptors / genetics
  • Humans
  • Indoles*
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Pyrimidines*

Substances

  • osimertinib
  • Acrylamides
  • Aniline Compounds
  • ErbB Receptors
  • EGFR protein, human
  • Indoles
  • Pyrimidines